Evidence map›Paper›PMID 32513899›Full record

ArticleMolecular cancer research : MCR2020

Metastasis-Specific Gene Expression in Autochthonous and Allograft Mouse Mammary Tumor Models: Stratification and Identification of Targetable Signatures.

Christina Ross, Karol Szczepanek, Maxwell Lee, Howard Yang, Cody J Peer, Jessica Kindrick, Priya Shankarappa, Zhi-Wei Lin, Jack D Sanford, William D Figg and 1 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Molecular cancer research : MCR, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Mouse Models of Metastasis and Dormancy.Cold Spring Harbor perspectives in medicine · 2024
    Review
  5. Article
  6. SMARCD1 is a "Goldilocks" metastasis modifier.bioRxiv : the preprint server for biology · 2024
    Article
  7. Article
  8. An engineered niche delineates metastatic potential of breast cancer.Bioengineering & translational medicine · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. The In Vivo Selection Method in Breast Cancer Metastasis.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Christina RossLaboratory of Cancer Biology and Genetics, Metastasis Susceptibility Section, Center for Cancer Research, NCI, Bethesda, Maryland.
Karol SzczepanekLaboratory of Cancer Biology and Genetics, Metastasis Susceptibility Section, Center for Cancer Research, NCI, Bethesda, Maryland.
Maxwell LeeLaboratory of Cancer Biology and Genetics, High-Dimension Data Analysis Group, Center for Cancer Research, NCI, Bethesda, Maryland.
Howard YangLaboratory of Cancer Biology and Genetics, High-Dimension Data Analysis Group, Center for Cancer Research, NCI, Bethesda, Maryland.ORCID 0000-0002-9291-631X
Cody J PeerClinical Pharmacology Program, Office of the Clinical Director, NCI, NIH, Bethesda, Maryland.ORCID 0000-0001-9395-3473
Jessica KindrickClinical Pharmacology Program, Office of the Clinical Director, NCI, NIH, Bethesda, Maryland.
Priya ShankarappaClinical Pharmacology Program, Office of the Clinical Director, NCI, NIH, Bethesda, Maryland.
Zhi-Wei LinClinical Pharmacology Program, Office of the Clinical Director, NCI, NIH, Bethesda, Maryland.
Jack D SanfordLaboratory of Cancer Biology and Genetics, Metastasis Susceptibility Section, Center for Cancer Research, NCI, Bethesda, Maryland.ORCID 0000-0001-6054-9685
William D FiggClinical Pharmacology Program, Office of the Clinical Director, NCI, NIH, Bethesda, Maryland.ORCID 0000-0003-2428-5613
Kent W HunterLaboratory of Cancer Biology and Genetics, Metastasis Susceptibility Section, Center for Cancer Research, NCI, Bethesda, Maryland. hunterk@mail.nih.gov.ORCID 0000-0001-5963-8808
Office of the Director · USCenter for Cancer Research · USCancer Genetics (United States) · US

Funding

Genetic Modifiers of Intitiation and Progression of Mammary CancerZIABC011255 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HUNTER, KENT WILLIAM · 2010 to 2025
$33.2M
Using Clinical Pharmacology Principles to Develop New Anticancer TherapiesZICSC006537 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI FIGG, WILLIAM DOUGLAS · 2009 to 2025
$14.4M
Integrated analyses of genetics, epigenetics, and gene expressionZIHBC011703 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LEE, MAXWELL · 2016 to 2025
$10.9M
Intramural NIH HHS Z99 CA999999Intramural NIH HHS ZIA BC011255
6 · The paper itself

Abstract

Breast cancer metastasis is a leading cause of cancer-related death of women in the United States. A hurdle in advancing metastasis-targeted intervention is the phenotypic heterogeneity between primary and secondary lesions. To identify metastasis-specific gene expression profiles we performed RNA-sequencing of breast cancer mouse models; analyzing metastases from models of various drivers and routes. We contrasted the models and identified common, targetable signatures. Allograft models exhibited more mesenchymal-like gene expression than genetically engineered mouse models (GEMM), and primary culturing of GEMM-derived metastatic tissue induced mesenchymal-like gene expression. In addition, metastasis-specific transcriptomes differed between tail vein and orthotopic injection of the same cell line. Gene expression common to models of spontaneous metastasis included sildenafil response and nicotine degradation pathways. Strikingly,

Indexed as

AllograftsAnimalsCell Line, TumorChromatography, LiquidFemaleGene Expression Regulation, NeoplasticMaleMammary Neoplasms, ExperimentalMiceMice, Inbred C57BLNeoplasm MetastasisNeoplasm TransplantationTandem Mass Spectrometry

Identifiers

PMID32513899
PMCPMC7483845
OpenAlexW3033912454

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.